COM:SEQUANAMEDICAL
Sequana Medical NV
- Stock
Last Close
0.85
25/11 08:49
Market Cap
40.33M
Beta: -
Volume Today
3.44K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.77M - | 2.05M 16.36% | 1.62M 21.26% | 1.25M 22.51% | 1.42M 13.04% | 1.53M 8.34% | 1.81M 17.65% | 2.38M 31.83% | 2.46M 3.29% | ||
average payables | 1.29M - | 1.55M 20.81% | 1.36M 12.72% | 1.41M 3.86% | 1.80M 27.64% | 1.85M 2.93% | 2.10M 13.66% | 2.71M 28.87% | 3.07M 13.17% | ||
average receivables | 187.77K - | 668.75K - | 1.15M 71.30% | 1.05M 8.15% | 575.41K 45.31% | 224.60K 60.97% | |||||
book value per share | -0.02 - | -0.49 2,242.31% | -0.34 30.85% | -1.37 306.88% | 0.08 105.48% | 0.01 90.22% | -0.04 686.63% | -0.09 118.87% | |||
capex per share | -0.01 - | -0.02 141.74% | -0.00 96.96% | -0.00 492.71% | -0.03 857.58% | -0.01 66.72% | -0.02 98.42% | -0.03 66.16% | |||
capex to depreciation | -1.91 - | -2.68 40.45% | -0.08 96.88% | -0.48 471.74% | -1.36 185.32% | -0.45 67.00% | -0.80 77.11% | -2.17 172.42% | -1.08 50.49% | ||
capex to operating cash flow | 0.01 - | 0.02 113.52% | 0.00 95.38% | 0.00 402.83% | 0.02 360.72% | 0.01 54.96% | 0.01 69.96% | 0.02 78.52% | 0.02 3.73% | ||
capex to revenue | -0.05 - | -0.14 173.58% | -0.00 96.53% | -0.04 650.97% | -0.34 814.26% | -0.14 58.24% | -0.88 513.70% | -0.73 16.59% | -1.00 36.15% | ||
cash per share | 0.10 - | 0.06 44.12% | 0.12 111.15% | 0.10 21.74% | 0.45 370.82% | 0.72 58.37% | 0.53 26.74% | 0.83 57.26% | |||
days of inventory on hand | 2.18K - | 2.24K 2.69% | 2.18K 2.39% | 2.85K 30.66% | 2.95K 3.36% | 2.65K 10.00% | 10.19K 283.83% | 4.68K 54.09% | 172.22 96.32% | ||
days payables outstanding | 1.33K - | 2.05K 55.04% | 1.56K 23.98% | 4.41K 182.13% | 3.11K 29.31% | 3.63K 16.56% | 10.44K 187.60% | 5.76K 44.86% | 218.05 96.21% | ||
days sales outstanding | 502.96 - | 361.34 28.16% | 1.13K 213.76% | 22.04 - | |||||||
debt to assets | 1.22 - | 1.30 6.19% | 4.39 237.19% | 0.34 92.14% | 0.55 60.34% | 0.55 0.57% | 0.68 22.94% | 1.69 149.80% | |||
debt to equity | -0.70 - | -0.99 41.93% | -0.78 21.32% | 3.48 545.81% | 69.70 1,901.37% | -10.27 114.74% | -8.17 20.48% | -0.88 89.28% | |||
dividend yield | |||||||||||
earnings yield | -0.10 - | -0.12 20.92% | -0.07 41.14% | -0.12 70.00% | -0.19 59.99% | -0.11 45.65% | -0.17 62.17% | -0.23 31.29% | |||
enterprise value | -4.09M - | 113.55M 2,875.69% | 118.84M 4.66% | 117.87M 0.82% | 128.31M 8.86% | 74.61M 41.85% | 177.50M 137.90% | 136.17M 23.28% | 135.33M 0.62% | 14.94M 88.96% | |
enterprise value over ebitda | -9.98 - | -8.70 12.86% | -15.73 80.85% | -9.90 37.04% | -5.40 45.51% | -10.10 87.25% | -6.12 39.40% | -4.82 21.27% | -0.52 89.25% | ||
ev to operating cash flow | -10.08 - | -9.32 7.56% | -14.07 50.91% | -12.99 7.65% | -4.04 68.93% | -10.44 158.57% | -5.77 44.76% | -4.92 14.59% | -0.50 89.89% | ||
ev to sales | 67.39 - | 79.83 18.45% | 90.39 13.24% | 124.68 37.93% | 76.87 38.35% | 184.27 139.72% | 367.54 99.46% | 146.67 60.09% | 20.98 85.70% | ||
free cash flow per share | -0.83 - | -0.95 14.22% | -0.61 35.32% | -0.73 18.24% | -1.53 110.77% | -1.12 26.82% | -1.31 17.40% | -1.24 5.93% | |||
free cash flow yield | -0.10 - | -0.11 14.22% | -0.07 35.32% | -0.09 18.24% | -0.24 183.49% | -0.09 61.18% | -0.17 83.25% | -0.21 18.53% | |||
graham net net | -0.18 - | -0.64 252.42% | -0.43 33.18% | -1.48 247.04% | -0.08 94.30% | -0.11 26.66% | -0.22 103.73% | -0.35 61.49% | |||
graham number | 0.63 - | 3.35 432.21% | 2.14 36.20% | 5.63 163.00% | 1.44 74.47% | 0.45 68.34% | 1.12 146.88% | 1.70 51.02% | |||
income quality | 0.97 - | 0.91 6.37% | 1.02 11.66% | 0.71 30.66% | 1.23 74.73% | 0.89 27.87% | 1.00 12.37% | 0.89 10.67% | 0.92 3.10% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -129.06 - | -72.30 43.98% | -11.91 83.52% | -14.14 18.70% | -18.26 29.12% | -16.62 9.00% | -39.56 138.09% | -32.26 18.46% | -6.88 78.68% | ||
interest debt per share | 0.01 - | 0.36 5,384.24% | 0.38 7.40% | 1.14 198.79% | 0.32 71.52% | 0.58 79.62% | 0.48 18.55% | 0.81 70.66% | |||
inventory turnover | 0.17 - | 0.16 2.62% | 0.17 2.45% | 0.13 23.46% | 0.12 3.25% | 0.14 11.12% | 0.04 73.95% | 0.08 117.83% | 2.12 2,615.19% | ||
invested capital | -0.70 - | -0.99 41.93% | -0.78 21.32% | 3.48 545.81% | 69.70 1,901.37% | -10.27 114.74% | -8.17 20.48% | -0.88 89.28% | |||
market cap | 114.98M - | 114.98M 0% | 114.98M 0% | 114.98M 0% | 76.97M 33.05% | 180.66M 134.70% | 137.69M 23.78% | 136.62M 0.78% | |||
net current asset value | 2.66M - | -546.27K 120.54% | -7.07M 1,194.26% | -4.86M 31.28% | -19.00M 291.11% | 97.39K 100.51% | -659.26K 776.94% | -2.60M 294.61% | -5.09M 95.63% | -23.27M 357.27% | |
net debt to ebitda | 0.13 - | -0.28 325.62% | -0.39 36.47% | -1.03 166.53% | 0.17 116.60% | 0.18 5.20% | 0.07 62.09% | 0.05 32.93% | -0.52 1,233.80% | ||
net income per share | -0.85 - | -1.02 20.92% | -0.60 41.14% | -1.02 70.00% | -1.22 18.95% | -1.25 2.45% | -1.30 3.90% | -1.35 4.20% | |||
operating cash flow per share | -0.82 - | -0.93 13.22% | -0.61 34.28% | -0.72 17.87% | -1.50 107.85% | -1.11 26.11% | -1.30 16.75% | -1.21 6.92% | |||
payables turnover | 0.28 - | 0.18 35.50% | 0.23 31.55% | 0.08 64.56% | 0.12 41.47% | 0.10 14.21% | 0.03 65.23% | 0.06 81.34% | 1.67 2,540.38% | ||
receivables turnover | 0.73 - | 1.01 39.19% | 0.32 68.13% | 16.56 - | |||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -2.47 - | -3.67 48.69% | -2.34 36.32% | -4.19 79.06% | -1.60 61.73% | -1.34 16.08% | -1.61 19.47% | -1.18 26.39% | -3.22 172.73% | ||
revenue per share | 0.12 - | 0.11 11.64% | 0.10 12.41% | 0.08 21.07% | 0.08 4.74% | 0.06 20.30% | 0.02 67.67% | 0.04 99.20% | |||
roe | 40.60 - | 2.10 94.84% | 1.78 14.89% | 0.75 58.22% | -16.18 2,270.09% | -169.44 947.50% | 30.01 117.71% | 14.29 52.39% | 1.67 88.29% | ||
roic | 40.29 - | 6.88 82.92% | 230.56 3,250.99% | 3.18 98.62% | -3.05 195.89% | -2.16 29.32% | -2.86 32.57% | -1.76 38.50% | 15.38 974.73% | ||
sales general and administrative to revenue | 1.95 - | 2.73 39.80% | 1.52 44.08% | 5.60 267.20% | 4.39 21.52% | 4.58 4.36% | 13.76 200.13% | 7.25 47.33% | |||
shareholders equity per share | -0.02 - | -0.49 2,242.31% | -0.34 30.85% | -1.37 306.88% | 0.08 105.48% | 0.01 90.22% | -0.04 686.63% | -0.09 118.87% | |||
stock based compensation to revenue | 0.01 - | 0.01 5.97% | 0.02 174.24% | 0.23 1,228.17% | 0.40 71.53% | 0.27 33.75% | 1.45 445.06% | 0.61 57.75% | |||
tangible asset value | 2.85M - | -284.66K 109.99% | -6.67M 2,242.31% | -4.61M 30.85% | -18.76M 306.88% | 925.93K 104.94% | 112.76K 87.82% | -786.92K 797.86% | -2.15M 173.63% | -19.47M 804.03% | |
tangible book value per share | -0.02 - | -0.49 2,242.31% | -0.34 30.85% | -1.37 306.88% | 0.08 105.48% | 0.01 90.22% | -0.04 686.63% | -0.09 118.87% | |||
working capital | 3.40M - | 299.85K 91.17% | -1.44M 579.49% | -2.28M 58.76% | -15.63M 584.64% | 3.21M 120.52% | 7.48M 133.10% | 5.71M 23.61% | 7.94M 39.06% | -13.17M 265.84% |
All numbers in EUR (except ratios and percentages)